Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Consolidated Statements of Operations
Net sales	$ 3,366,631	$ 2,214,956	$ 1,515,139
Cost of goods sold	(3,103,392)	(2,074,817)	(1,426,112)
Gross profit	263,239	140,139	89,027
Selling, general and administrative expenses	(217,302)	(127,556)	(77,944)
Income from operations	45,937	12,583	11,083
Other (expense) income:
Interest expense	(5,239)	(2,528)	(1,996)
Change in fair value of redeemable common shares		9,073	(34,348)
Termination of existing stock redemption agreement		(4,842)
Equity loss and impairment of non-consolidated entity		(6,208)	(1,055)
Other	308	1,128	196
Total other expense	(4,931)	(3,377)	(37,203)
Income (loss) before income taxes	41,006	9,206	(26,120)
Income tax expense	(16,234)	(4,655)
Net income (loss)	24,772	4,551	(26,120)
Less net loss attributable to noncontrolling interest	(1,004)	(225)
Net income (loss) attributable to Diplomat Pharmacy, Inc.	25,776	4,776	(26,120)
Net income allocable to preferred shareholders		458
Net income (loss) allocable to common shareholders	$ 25,776	$ 4,318	$ (26,120)
Net income (loss) per common share:
Basic (in dollars per share)	$ 0.42	$ 0.12	$ (0.79)
Diluted (in dollars per share)	$ 0.41	$ 0.11	$ (0.79)
Weighted average common shares outstanding:
Basic (in shares)	60,730,133	36,012,592	33,141,500
Diluted (in shares)	63,096,951	38,553,995	33,141,500